K

Kiniksa Pharmaceuticals Ltd
D

KNSA

28.390
USD
0.10
(0.35%)
مغلق
حجم التداول
29,707
الربح لكل سهم
0
العائد الربحي
-
P/E
-118
حجم السوق
2,071,645,753
أصول ذات صلة
A
ASND
7.060
(4.14%)
177.740 USD
ICLR
ICLR
1.280
(0.88%)
147.000 USD
M
MCRB
-0.04000
(-0.53%)
7.50000 USD
M
MGNX
-0.01500
(-0.98%)
1.51000 USD
O
OMER
-0.04000
(-1.18%)
3.36000 USD
R
RDFN
-0.025
(-0.23%)
10.785 USD
S
SGMO
0.01500
(3.12%)
0.49510 USD
TEVA
TEVA
0.530
(3.12%)
17.510 USD
VRTX
VRTX
-4.92
(-1.08%)
450.78 USD
المزيد
الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.